Global Nanobiotechnology Market Research Report 2022

SKU ID : QYR-21348717 | Publishing Date : 18-Jul-2022 | No. of pages : 109

Request a free Sample

Detailed TOC of Global Nanobiotechnology Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Nanomedicine
        1.2.3 Nano Medical Devices
        1.2.4 Nano Diagnosis
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Nanobiotechnology Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Anticancer
        1.3.3 CNS Product
        1.3.4 Anti-infective
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Nanobiotechnology Market Perspective (2017-2028)
    2.2 Nanobiotechnology Growth Trends by Region
        2.2.1 Nanobiotechnology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Nanobiotechnology Historic Market Size by Region (2017-2022)
        2.2.3 Nanobiotechnology Forecasted Market Size by Region (2023-2028)
    2.3 Nanobiotechnology Market Dynamics
        2.3.1 Nanobiotechnology Industry Trends
        2.3.2 Nanobiotechnology Market Drivers
        2.3.3 Nanobiotechnology Market Challenges
        2.3.4 Nanobiotechnology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Nanobiotechnology Players by Revenue
        3.1.1 Global Top Nanobiotechnology Players by Revenue (2017-2022)
        3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2017-2022)
    3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Nanobiotechnology Revenue
    3.4 Global Nanobiotechnology Market Concentration Ratio
        3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2021
    3.5 Nanobiotechnology Key Players Head office and Area Served
    3.6 Key Players Nanobiotechnology Product Solution and Service
    3.7 Date of Enter into Nanobiotechnology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Nanobiotechnology Breakdown Data by Type
    4.1 Global Nanobiotechnology Historic Market Size by Type (2017-2022)
    4.2 Global Nanobiotechnology Forecasted Market Size by Type (2023-2028)
5 Nanobiotechnology Breakdown Data by Application
    5.1 Global Nanobiotechnology Historic Market Size by Application (2017-2022)
    5.2 Global Nanobiotechnology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Nanobiotechnology Market Size (2017-2028)
    6.2 North America Nanobiotechnology Market Size by Country (2017-2022)
    6.3 North America Nanobiotechnology Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Nanobiotechnology Market Size (2017-2028)
    7.2 Europe Nanobiotechnology Market Size by Country (2017-2022)
    7.3 Europe Nanobiotechnology Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Nanobiotechnology Market Size (2017-2028)
    8.2 Asia-Pacific Nanobiotechnology Market Size by Country (2017-2022)
    8.3 Asia-Pacific Nanobiotechnology Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Nanobiotechnology Market Size (2017-2028)
    9.2 Latin America Nanobiotechnology Market Size by Country (2017-2022)
    9.3 Latin America Nanobiotechnology Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Nanobiotechnology Market Size (2017-2028)
    10.2 Middle East & Africa Nanobiotechnology Market Size by Country (2017-2022)
    10.3 Middle East & Africa Nanobiotechnology Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Nanobiotechnology Introduction
        11.1.4 Amgen Revenue in Nanobiotechnology Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 Teva Pharmaceuticals
        11.2.1 Teva Pharmaceuticals Company Detail
        11.2.2 Teva Pharmaceuticals Business Overview
        11.2.3 Teva Pharmaceuticals Nanobiotechnology Introduction
        11.2.4 Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2017-2022)
        11.2.5 Teva Pharmaceuticals Recent Development
    11.3 Abbott
        11.3.1 Abbott Company Detail
        11.3.2 Abbott Business Overview
        11.3.3 Abbott Nanobiotechnology Introduction
        11.3.4 Abbott Revenue in Nanobiotechnology Business (2017-2022)
        11.3.5 Abbott Recent Development
    11.4 UCB
        11.4.1 UCB Company Detail
        11.4.2 UCB Business Overview
        11.4.3 UCB Nanobiotechnology Introduction
        11.4.4 UCB Revenue in Nanobiotechnology Business (2017-2022)
        11.4.5 UCB Recent Development
    11.5 Roche
        11.5.1 Roche Company Detail
        11.5.2 Roche Business Overview
        11.5.3 Roche Nanobiotechnology Introduction
        11.5.4 Roche Revenue in Nanobiotechnology Business (2017-2022)
        11.5.5 Roche Recent Development
    11.6 Celgene
        11.6.1 Celgene Company Detail
        11.6.2 Celgene Business Overview
        11.6.3 Celgene Nanobiotechnology Introduction
        11.6.4 Celgene Revenue in Nanobiotechnology Business (2017-2022)
        11.6.5 Celgene Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Detail
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Nanobiotechnology Introduction
        11.7.4 Sanofi Revenue in Nanobiotechnology Business (2017-2022)
        11.7.5 Sanofi Recent Development
    11.8 Merck & Co
        11.8.1 Merck & Co Company Detail
        11.8.2 Merck & Co Business Overview
        11.8.3 Merck & Co Nanobiotechnology Introduction
        11.8.4 Merck & Co Revenue in Nanobiotechnology Business (2017-2022)
        11.8.5 Merck & Co Recent Development
    11.9 Biogen
        11.9.1 Biogen Company Detail
        11.9.2 Biogen Business Overview
        11.9.3 Biogen Nanobiotechnology Introduction
        11.9.4 Biogen Revenue in Nanobiotechnology Business (2017-2022)
        11.9.5 Biogen Recent Development
    11.10 Stryker
        11.10.1 Stryker Company Detail
        11.10.2 Stryker Business Overview
        11.10.3 Stryker Nanobiotechnology Introduction
        11.10.4 Stryker Revenue in Nanobiotechnology Business (2017-2022)
        11.10.5 Stryker Recent Development
    11.11 Gilead Sciences
        11.11.1 Gilead Sciences Company Detail
        11.11.2 Gilead Sciences Business Overview
        11.11.3 Gilead Sciences Nanobiotechnology Introduction
        11.11.4 Gilead Sciences Revenue in Nanobiotechnology Business (2017-2022)
        11.11.5 Gilead Sciences Recent Development
    11.12 Pfizer
        11.12.1 Pfizer Company Detail
        11.12.2 Pfizer Business Overview
        11.12.3 Pfizer Nanobiotechnology Introduction
        11.12.4 Pfizer Revenue in Nanobiotechnology Business (2017-2022)
        11.12.5 Pfizer Recent Development
    11.13 3M Company
        11.13.1 3M Company Company Detail
        11.13.2 3M Company Business Overview
        11.13.3 3M Company Nanobiotechnology Introduction
        11.13.4 3M Company Revenue in Nanobiotechnology Business (2017-2022)
        11.13.5 3M Company Recent Development
    11.14 Johnson & Johnson
        11.14.1 Johnson & Johnson Company Detail
        11.14.2 Johnson & Johnson Business Overview
        11.14.3 Johnson & Johnson Nanobiotechnology Introduction
        11.14.4 Johnson & Johnson Revenue in Nanobiotechnology Business (2017-2022)
        11.14.5 Johnson & Johnson Recent Development
    11.15 Smith & Nephew
        11.15.1 Smith & Nephew Company Detail
        11.15.2 Smith & Nephew Business Overview
        11.15.3 Smith & Nephew Nanobiotechnology Introduction
        11.15.4 Smith & Nephew Revenue in Nanobiotechnology Business (2017-2022)
        11.15.5 Smith & Nephew Recent Development
    11.16 Leadiant Biosciences
        11.16.1 Leadiant Biosciences Company Detail
        11.16.2 Leadiant Biosciences Business Overview
        11.16.3 Leadiant Biosciences Nanobiotechnology Introduction
        11.16.4 Leadiant Biosciences Revenue in Nanobiotechnology Business (2017-2022)
        11.16.5 Leadiant Biosciences Recent Development
    11.17 Kyowa Hakko Kirin
        11.17.1 Kyowa Hakko Kirin Company Detail
        11.17.2 Kyowa Hakko Kirin Business Overview
        11.17.3 Kyowa Hakko Kirin Nanobiotechnology Introduction
        11.17.4 Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2017-2022)
        11.17.5 Kyowa Hakko Kirin Recent Development
    11.18 Shire
        11.18.1 Shire Company Detail
        11.18.2 Shire Business Overview
        11.18.3 Shire Nanobiotechnology Introduction
        11.18.4 Shire Revenue in Nanobiotechnology Business (2017-2022)
        11.18.5 Shire Recent Development
    11.19 Ipsen
        11.19.1 Ipsen Company Detail
        11.19.2 Ipsen Business Overview
        11.19.3 Ipsen Nanobiotechnology Introduction
        11.19.4 Ipsen Revenue in Nanobiotechnology Business (2017-2022)
        11.19.5 Ipsen Recent Development
    11.20 Endo International
        11.20.1 Endo International Company Detail
        11.20.2 Endo International Business Overview
        11.20.3 Endo International Nanobiotechnology Introduction
        11.20.4 Endo International Revenue in Nanobiotechnology Business (2017-2022)
        11.20.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Nanobiotechnology Market Research Report 2022

List of Tables
    Table 1. Global Nanobiotechnology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Nanomedicine
    Table 3. Key Players of Nano Medical Devices
    Table 4. Key Players of Nano Diagnosis
    Table 5. Key Players of Other
    Table 6. Global Nanobiotechnology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Nanobiotechnology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Nanobiotechnology Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Nanobiotechnology Market Share by Region (2017-2022)
    Table 10. Global Nanobiotechnology Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Nanobiotechnology Market Share by Region (2023-2028)
    Table 12. Nanobiotechnology Market Trends
    Table 13. Nanobiotechnology Market Drivers
    Table 14. Nanobiotechnology Market Challenges
    Table 15. Nanobiotechnology Market Restraints
    Table 16. Global Nanobiotechnology Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Nanobiotechnology Market Share by Players (2017-2022)
    Table 18. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2021)
    Table 19. Ranking of Global Top Nanobiotechnology Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Nanobiotechnology Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Nanobiotechnology Product Solution and Service
    Table 23. Date of Enter into Nanobiotechnology Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Nanobiotechnology Revenue Market Share by Type (2017-2022)
    Table 27. Global Nanobiotechnology Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Nanobiotechnology Revenue Market Share by Type (2023-2028)
    Table 29. Global Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Nanobiotechnology Revenue Market Share by Application (2017-2022)
    Table 31. Global Nanobiotechnology Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Nanobiotechnology Revenue Market Share by Application (2023-2028)
    Table 33. North America Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Nanobiotechnology Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Nanobiotechnology Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Amgen Company Detail
    Table 44. Amgen Business Overview
    Table 45. Amgen Nanobiotechnology Product
    Table 46. Amgen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 47. Amgen Recent Development
    Table 48. Teva Pharmaceuticals Company Detail
    Table 49. Teva Pharmaceuticals Business Overview
    Table 50. Teva Pharmaceuticals Nanobiotechnology Product
    Table 51. Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 52. Teva Pharmaceuticals Recent Development
    Table 53. Abbott Company Detail
    Table 54. Abbott Business Overview
    Table 55. Abbott Nanobiotechnology Product
    Table 56. Abbott Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 57. Abbott Recent Development
    Table 58. UCB Company Detail
    Table 59. UCB Business Overview
    Table 60. UCB Nanobiotechnology Product
    Table 61. UCB Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 62. UCB Recent Development
    Table 63. Roche Company Detail
    Table 64. Roche Business Overview
    Table 65. Roche Nanobiotechnology Product
    Table 66. Roche Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 67. Roche Recent Development
    Table 68. Celgene Company Detail
    Table 69. Celgene Business Overview
    Table 70. Celgene Nanobiotechnology Product
    Table 71. Celgene Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 72. Celgene Recent Development
    Table 73. Sanofi Company Detail
    Table 74. Sanofi Business Overview
    Table 75. Sanofi Nanobiotechnology Product
    Table 76. Sanofi Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 77. Sanofi Recent Development
    Table 78. Merck & Co Company Detail
    Table 79. Merck & Co Business Overview
    Table 80. Merck & Co Nanobiotechnology Product
    Table 81. Merck & Co Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 82. Merck & Co Recent Development
    Table 83. Biogen Company Detail
    Table 84. Biogen Business Overview
    Table 85. Biogen Nanobiotechnology Product
    Table 86. Biogen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 87. Biogen Recent Development
    Table 88. Stryker Company Detail
    Table 89. Stryker Business Overview
    Table 90. Stryker Nanobiotechnology Product
    Table 91. Stryker Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 92. Stryker Recent Development
    Table 93. Gilead Sciences Company Detail
    Table 94. Gilead Sciences Business Overview
    Table 95. Gilead Sciences NanobiotechnologyProduct
    Table 96. Gilead Sciences Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 97. Gilead Sciences Recent Development
    Table 98. Pfizer Company Detail
    Table 99. Pfizer Business Overview
    Table 100. Pfizer NanobiotechnologyProduct
    Table 101. Pfizer Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 102. Pfizer Recent Development
    Table 103. 3M Company Company Detail
    Table 104. 3M Company Business Overview
    Table 105. 3M Company NanobiotechnologyProduct
    Table 106. 3M Company Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 107. 3M Company Recent Development
    Table 108. Johnson & Johnson Company Detail
    Table 109. Johnson & Johnson Business Overview
    Table 110. Johnson & Johnson NanobiotechnologyProduct
    Table 111. Johnson & Johnson Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 112. Johnson & Johnson Recent Development
    Table 113. Smith & Nephew Company Detail
    Table 114. Smith & Nephew Business Overview
    Table 115. Smith & Nephew NanobiotechnologyProduct
    Table 116. Smith & Nephew Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 117. Smith & Nephew Recent Development
    Table 118. Leadiant Biosciences Company Detail
    Table 119. Leadiant Biosciences Business Overview
    Table 120. Leadiant Biosciences NanobiotechnologyProduct
    Table 121. Leadiant Biosciences Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 122. Leadiant Biosciences Recent Development
    Table 123. Kyowa Hakko Kirin Company Detail
    Table 124. Kyowa Hakko Kirin Business Overview
    Table 125. Kyowa Hakko Kirin NanobiotechnologyProduct
    Table 126. Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 127. Kyowa Hakko Kirin Recent Development
    Table 128. Shire Company Detail
    Table 129. Shire Business Overview
    Table 130. Shire NanobiotechnologyProduct
    Table 131. Shire Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 132. Shire Recent Development
    Table 133. Ipsen Company Detail
    Table 134. Ipsen Business Overview
    Table 135. Ipsen NanobiotechnologyProduct
    Table 136. Ipsen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 137. Ipsen Recent Development
    Table 138. Endo International Company Detail
    Table 139. Endo International Business Overview
    Table 140. Endo International NanobiotechnologyProduct
    Table 141. Endo International Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million)
    Table 142. Endo International Recent Development
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nanobiotechnology Market Share by Type: 2021 VS 2028
    Figure 2. Nanomedicine Features
    Figure 3. Nano Medical Devices Features
    Figure 4. Nano Diagnosis Features
    Figure 5. Other Features
    Figure 6. Global Nanobiotechnology Market Share by Application in 2021 & 2028
    Figure 7. Anticancer Case Studies
    Figure 8. CNS Product Case Studies
    Figure 9. Anti-infective Case Studies
    Figure 10. Other Case Studies
    Figure 11. Nanobiotechnology Report Years Considered
    Figure 12. Global Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Nanobiotechnology Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Nanobiotechnology Market Share by Region: 2021 VS 2028
    Figure 15. Global Nanobiotechnology Market Share by Players in 2021
    Figure 16. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Nanobiotechnology Revenue in 2021
    Figure 18. North America Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Nanobiotechnology Market Share by Country (2017-2028)
    Figure 20. United States Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Nanobiotechnology Market Share by Country (2017-2028)
    Figure 24. Germany Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Nanobiotechnology Market Share by Region (2017-2028)
    Figure 32. China Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Nanobiotechnology Market Share by Country (2017-2028)
    Figure 40. Mexico Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Nanobiotechnology Market Share by Country (2017-2028)
    Figure 44. Turkey Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Amgen Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 48. Abbott Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 49. UCB Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 50. Roche Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 51. Celgene Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 52. Sanofi Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 53. Merck & Co Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 54. Biogen Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 55. Stryker Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 56. Gilead Sciences Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 58. 3M Company Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 60. Smith & Nephew Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 61. Leadiant Biosciences Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 62. Kyowa Hakko Kirin Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 63. Shire Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 64. Ipsen Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 65. Endo International Revenue Growth Rate in Nanobiotechnology Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed

Keyplayers in Global Nanobiotechnology Market Research Report 2022

Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International